Pereira, R.B.; Evdokimov, N.M.; Lefranc, F.; Valentão, P.; Kornienko, A.; Pereira, D.M.; Andrade, P.B.; Gomes, N.G.M.
Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets. Mar. Drugs 2019, 17, 329.
https://doi.org/10.3390/md17060329
AMA Style
Pereira RB, Evdokimov NM, Lefranc F, Valentão P, Kornienko A, Pereira DM, Andrade PB, Gomes NGM.
Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets. Marine Drugs. 2019; 17(6):329.
https://doi.org/10.3390/md17060329
Chicago/Turabian Style
Pereira, Renato B., Nikolai M. Evdokimov, Florence Lefranc, Patrícia Valentão, Alexander Kornienko, David M. Pereira, Paula B. Andrade, and Nelson G. M. Gomes.
2019. "Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets" Marine Drugs 17, no. 6: 329.
https://doi.org/10.3390/md17060329
APA Style
Pereira, R. B., Evdokimov, N. M., Lefranc, F., Valentão, P., Kornienko, A., Pereira, D. M., Andrade, P. B., & Gomes, N. G. M.
(2019). Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets. Marine Drugs, 17(6), 329.
https://doi.org/10.3390/md17060329